Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain

Leishmania (Leishmania) infantum is the causative agent of both the cutaneous and visceral forms of leishmaniasis in southwest Europe; the dog is the main reservoir. In order to identify the L. (L.) infantum zymodemes present in Spain, a total number of 85 Leishmania stocks isolated from dogs (31),...

Full description

Saved in:
Bibliographic Details
Published inFEMS microbiology letters Vol. 131; no. 2; pp. 197 - 204
Main Authors Jiménez, Maribel, Ferrer-Dufol, Montserrat, Cañavate, Carmen, Gutiérrez-Solar, Beatriz, Molina, Ricardo, Lagun, Fernando, López-Vélez, Rogelio, Cercenado, Emilia, Daudén, Esteban, Blazquez, Julio, Guevara, Conception Ladrón de, Gómez, Javier, de la Torre, Julian, Barros, Carlos, Altes, Jordi, Serra, Teresa, Alvar, Jorge
Format Journal Article
LanguageEnglish
Published Oxford Elsevier B.V 01.09.1995
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Leishmania (Leishmania) infantum is the causative agent of both the cutaneous and visceral forms of leishmaniasis in southwest Europe; the dog is the main reservoir. In order to identify the L. (L.) infantum zymodemes present in Spain, a total number of 85 Leishmania stocks isolated from dogs (31), HIV-positive patients (46) with visceral or cutaneous leishmaniasis, a patient with visceral leishmaniasis complicating renal transplantation (1) and immunocompetent patients (7) with visceral or cutaneous leishmaniasis, have been characterized by isoenzyme typing. All canine stocks were MON-1, which is the most widespread zymodeme in the Mediterranean area. In immunocompetent patients three zymodemes were found: MON-1 (2), MON-24 (2) and MON-34 (3). Nine different zymodemes were obtained in stocks from HTV co-infected patients, indicating a higher variability of L. (L.) infantum amongst them: MON-1 (in 21 stocks), MON-24 (7), MON-28 (1), MON-29 (3), MON-33 (7), MON-34 (1) and MON-183 (4). Two new zymodemes, MON-198 (1) and MON-199 (1), were described among HIV patients from Spain. The stock from the renal transplanted patient was MON-1. The exclusive presence of certain zymodemes in immunocompromised patients and their absence in typical cases of cutaneous and visceral
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0378-1097
1574-6968
DOI:10.1016/0378-1097(95)00259-8